The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses

被引:15
作者
Eller, Carla [1 ,2 ]
Heydmann, Laura [1 ,2 ]
Colpitts, Che C. [3 ]
Verrier, Eloi R. [1 ,2 ]
Schuster, Catherine [1 ,2 ]
Baumert, Thomas F. [1 ,2 ,4 ]
机构
[1] INSERM, U1110, Inst Rech Malad Virales & Hepat, 3 Rue Koeberle, F-67000 Strasbourg, France
[2] Univ Strasbourg, F-67000 Strasbourg, France
[3] UCL, Div Infect & Immun, London, England
[4] Nouvel Hop Civil, Pole Hepatodigestif, Inst Hospitalouniv, F-67000 Strasbourg, France
基金
加拿大健康研究院; 美国国家卫生研究院; 欧盟地平线“2020”;
关键词
Liver cell biology; Bile acid transport; Host factor; Anti-viral therapy; Hepatocytes; LARGE SURFACE PROTEIN; SALT EXPORT PUMP; HEPATOBILIARY TRANSPORTER EXPRESSION; BILE-ACID TRANSPORTERS; HEPARAN-SULFATE; CYCLOSPORINE-A; HEPATOCELLULAR-CARCINOMA; NUCLEAR RECEPTORS; ENTRY INHIBITORS; ENVELOPE PROTEIN;
D O I
10.1007/s00018-018-2892-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic hepatitis B, C and D virus (HBV, HCV and HDV) infections are a major cause of liver disease and cancer worldwide. Despite employing distinct replication strategies, the three viruses are exclusively hepatotropic, and therefore depend on hepatocyte-specific host factors. The sodium taurocholate co-transporting polypeptide (NTCP), a transmembrane protein highly expressed in human hepatocytes that mediates the transport of bile acids, plays a key role in HBV and HDV entry into hepatocytes. Recently, NTCP has been shown to modulate HCV infection of hepatocytes by regulating innate antiviral immune responses in the liver. Here, we review the current knowledge of the functional role and the molecular and cellular biology of NTCP in the life cycle of the three major hepatotropic viruses, highlight the impact of NTCP as an antiviral target and discuss future avenues of research.
引用
收藏
页码:3895 / 3905
页数:11
相关论文
共 118 条
  • [71] HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
    Nassal, Michael
    [J]. GUT, 2015, 64 (12) : 1972 - 1984
  • [72] IDENTIFICATION AND CHEMICAL SYNTHESIS OF A HOST-CELL RECEPTOR-BINDING SITE ON HEPATITIS-B VIRUS
    NEURATH, AR
    KENT, SBH
    STRICK, N
    PARKER, K
    [J]. CELL, 1986, 46 (03) : 429 - 436
  • [73] SEARCH FOR HEPATITIS-B VIRUS-CELL RECEPTORS REVEALS BINDING-SITES FOR INTERLEUKIN-6 ON THE VIRUS ENVELOPE PROTEIN
    NEURATH, AR
    STRICK, N
    SPROUL, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 461 - 469
  • [74] Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
    Ni, Yi
    Lempp, Florian A.
    Mehrle, Stefan
    Nkongolo, Shirin
    Kaufman, Christina
    Faelth, Maria
    Stindt, Jan
    Koeniger, Christian
    Nassal, Michael
    Kubitz, Ralf
    Sueltmann, Holger
    Urban, Stephan
    [J]. GASTROENTEROLOGY, 2014, 146 (04) : 1070 - U301
  • [75] Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
    Nkongolo, Shirin
    Ni, Yi
    Lempp, Florian A.
    Kaufman, Christina
    Lindner, Thomas
    Esser-Nobis, Katharina
    Lohmann, Volker
    Mier, Walter
    Mehrle, Stefan
    Urban, Stephan
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 723 - 731
  • [76] Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor
    Owen, David M.
    Huang, Hua
    Ye, Jin
    Gale, Michael, Jr.
    [J]. VIROLOGY, 2009, 394 (01) : 99 - 108
  • [77] Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations
    Pan, Wei
    Song, Im-Sook
    Shin, Ho-Jung
    Kim, Min-Hye
    Choi, Yeong-Lim
    Lim, Su-Jeong
    Kim, Woo-Young
    Lee, Sang-Seop
    Shin, Jae-Gook
    [J]. XENOBIOTICA, 2011, 41 (06) : 501 - 510
  • [78] The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
    Papatheodoridis, George V.
    Idilman, Ramazan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Luis Calleja, Jose
    Sypsa, Vana
    Goulis, John
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Ioannis
    Galanis, Kostantinos
    Yurdaydin, Cihan
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L. A.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2017, 66 (05) : 1444 - 1453
  • [79] The p.Ser267Phe Variant in SLC10A1 Is Associated With Resistance to Chronic Hepatitis B
    Peng, Liang
    Zhao, Qiang
    Li, Qibin
    Li, Miaoxin
    Li, Caixia
    Xu, Tingting
    Jing, Xiangyi
    Zhu, Xiang
    Wang, Ye
    Li, Fucheng
    Liu, Ruihong
    Zhong, Cheng
    Pan, Qihao
    Zeng, Binghui
    Liao, Qijun
    Hu, Bin
    Hu, Zhao-xia
    Huang, Yang-su
    Sham, Pak
    Liu, Jinsong
    Xu, Shuhua
    Wang, Jun
    Gao, Zhi-liang
    Wang, Yiming
    [J]. HEPATOLOGY, 2015, 61 (04) : 1251 - 1260
  • [80] THE PRES1 PROTEIN OF HEPATITIS-B VIRUS IS ACYLATED AT ITS AMINO TERMINUS WITH MYRISTIC ACID
    PERSING, DH
    VARMUS, HE
    GANEM, D
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (05) : 1672 - 1677